- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 18.11M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $340.67M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $369.51M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $5.49B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.44B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $6.28B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $6.19B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 17.94M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $8.26M |
| Capex | Q1 2025 · Mar 31, 2024 | $2.18M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $26.18M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $707.72M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $702.21M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.04 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.04 |
| Net Income | Q1 2025 · Mar 31, 2024 | $18.68M |